Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis - The Lancet Rheumatology

An Update for the Clinician on Biologics for the Treatment of

Head-to-head comparison of certolizumab pegol versus adalimumab in

An Integrated Analysis of the Safety of Tofacitinib in Psoriatic

Efficacy and safety of biologics in psoriatic arthritis: a

Sex- and gender-related differences in psoriatic arthritis

Comparative efficacy and safety of biologic therapies for moderate

JCM, Free Full-Text

Comparative efficacy and safety of biologic therapies for moderate

IJMS, Free Full-Text

Group for Research and Assessment of Psoriasis and Psoriatic

Expert Perspective: Management of the Psoriatic Arthritis Patient

Efficacy and safety of biologics in psoriatic arthritis: a

Association between biological immunotherapy for psoriasis and

The evolving demographics of participants in psoriatic arthritis

Signaling pathways in rheumatoid arthritis: implications for